CA3214673A1 - Systems and methods for heart valve therapy - Google Patents
Systems and methods for heart valve therapyInfo
- Publication number
- CA3214673A1 CA3214673A1 CA3214673A CA3214673A CA3214673A1 CA 3214673 A1 CA3214673 A1 CA 3214673A1 CA 3214673 A CA3214673 A CA 3214673A CA 3214673 A CA3214673 A CA 3214673A CA 3214673 A1 CA3214673 A1 CA 3214673A1
- Authority
- CA
- Canada
- Prior art keywords
- valve
- assembly
- anchor assembly
- anchor
- mitral valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 101
- 210000003709 heart valve Anatomy 0.000 title claims abstract description 23
- 238000002560 therapeutic procedure Methods 0.000 title description 9
- 210000004115 mitral valve Anatomy 0.000 claims abstract description 368
- 238000007789 sealing Methods 0.000 claims description 119
- 210000005246 left atrium Anatomy 0.000 claims description 73
- 230000002093 peripheral effect Effects 0.000 claims description 15
- 238000004873 anchoring Methods 0.000 claims description 10
- 238000004091 panning Methods 0.000 claims description 6
- 239000007943 implant Substances 0.000 claims description 2
- 210000003698 chordae tendineae Anatomy 0.000 abstract description 20
- 206010027727 Mitral valve incompetence Diseases 0.000 abstract description 19
- 230000002861 ventricular Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 210000003484 anatomy Anatomy 0.000 abstract description 7
- 239000012530 fluid Substances 0.000 abstract description 5
- 208000032750 Device leakage Diseases 0.000 abstract description 4
- 239000000463 material Substances 0.000 description 72
- 210000005240 left ventricle Anatomy 0.000 description 33
- 210000001519 tissue Anatomy 0.000 description 33
- 230000001746 atrial effect Effects 0.000 description 16
- 235000020637 scallop Nutrition 0.000 description 16
- 241000237509 Patinopecten sp. Species 0.000 description 15
- 230000006870 function Effects 0.000 description 13
- 238000002513 implantation Methods 0.000 description 13
- 230000008901 benefit Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 229910001000 nickel titanium Inorganic materials 0.000 description 8
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 8
- 210000001765 aortic valve Anatomy 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 6
- 229920009441 perflouroethylene propylene Polymers 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 210000005245 right atrium Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- CBOLARLSGQXRBB-UHFFFAOYSA-N 1-(oxiran-2-yl)-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1OC1)CC1CO1 CBOLARLSGQXRBB-UHFFFAOYSA-N 0.000 description 4
- 230000000712 assembly Effects 0.000 description 4
- 238000000429 assembly Methods 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- -1 polytetrafluoroethylene Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 210000003157 atrial septum Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 238000012876 topography Methods 0.000 description 3
- 210000000591 tricuspid valve Anatomy 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 210000001631 vena cava inferior Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 206010003658 Atrial Fibrillation Diseases 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 206010016803 Fluid overload Diseases 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 210000003102 pulmonary valve Anatomy 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- DSUFPYCILZXJFF-UHFFFAOYSA-N 4-[[4-[[4-(pentoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamoyloxy]butyl n-[4-[[4-(butoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamate Chemical compound C1CC(NC(=O)OCCCCC)CCC1CC1CCC(NC(=O)OCCCCOC(=O)NC2CCC(CC3CCC(CC3)NC(=O)OCCCC)CC2)CC1 DSUFPYCILZXJFF-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229910000599 Cr alloy Inorganic materials 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000020128 Mitral stenosis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000037198 cardiovascular physiology Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000000788 chromium alloy Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 1
- 230000010595 endothelial cell migration Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000006887 mitral valve stenosis Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
- A61F2/2448—D-shaped rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2403—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with pivoting rigid closure members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2436—Deployment by retracting a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2439—Expansion controlled by filaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/0078—Quadric-shaped hyperboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
- A61F2250/0063—Nested prosthetic parts
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462067907P | 2014-10-23 | 2014-10-23 | |
| US62/067,907 | 2014-10-23 | ||
| US14/671,577 | 2015-03-27 | ||
| US14/671,577 US9750605B2 (en) | 2014-10-23 | 2015-03-27 | Systems and methods for heart valve therapy |
| US14/673,055 US9750606B2 (en) | 2014-10-23 | 2015-03-30 | Systems and methods for heart valve therapy |
| US14/673,055 | 2015-03-30 | ||
| US14/674,349 | 2015-03-31 | ||
| US14/674,349 US9750607B2 (en) | 2014-10-23 | 2015-03-31 | Systems and methods for heart valve therapy |
| CA2964935A CA2964935C (en) | 2014-10-23 | 2015-10-22 | Systems and methods for heart valve therapy |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2964935A Division CA2964935C (en) | 2014-10-23 | 2015-10-22 | Systems and methods for heart valve therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3214673A1 true CA3214673A1 (en) | 2016-04-28 |
Family
ID=58553627
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3214673A Pending CA3214673A1 (en) | 2014-10-23 | 2015-10-22 | Systems and methods for heart valve therapy |
| CA2964935A Active CA2964935C (en) | 2014-10-23 | 2015-10-22 | Systems and methods for heart valve therapy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2964935A Active CA2964935C (en) | 2014-10-23 | 2015-10-22 | Systems and methods for heart valve therapy |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP6727218B2 (enExample) |
| CN (1) | CN107920862B (enExample) |
| AU (1) | AU2015335808B2 (enExample) |
| BR (1) | BR112017008423B1 (enExample) |
| CA (2) | CA3214673A1 (enExample) |
| IL (1) | IL251852B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4255348A4 (en) * | 2020-12-04 | 2024-08-28 | Hangzhou Sequoia Medical Device Co., Ltd | PROSTHETIC HEART VALVE DEVICE, SYSTEM AND METHODS |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020025118A2 (pt) * | 2018-07-10 | 2021-03-23 | Syntach Ag | dispositivo, sistema e procedimento de melhoramento de válvula cardíaca implantável |
| US12310850B2 (en) | 2018-09-20 | 2025-05-27 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
| US10653522B1 (en) * | 2018-12-20 | 2020-05-19 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valve prosthesis |
| US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
| WO2020146842A1 (en) | 2019-01-10 | 2020-07-16 | Vdyne, Llc | Anchor hook for side-delivery transcatheter heart valve prosthesis |
| WO2020167560A2 (en) * | 2019-02-12 | 2020-08-20 | Edwards Lifesciences Corporation | Controlled tissue anchor spacing |
| WO2020181154A2 (en) | 2019-03-05 | 2020-09-10 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
| AU2020267390B2 (en) | 2019-05-04 | 2025-12-04 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
| CN113599022A (zh) * | 2020-10-12 | 2021-11-05 | 宁波健世科技股份有限公司 | 一种便于操控的瓣膜假体输送系统 |
| CN116407356A (zh) * | 2021-12-31 | 2023-07-11 | 杭州德晋医疗科技有限公司 | 防滑脱的人工腱索植入装置及系统 |
| CN115670744A (zh) * | 2022-09-08 | 2023-02-03 | 赛诺心畅医疗科技有限公司 | 一种心脏瓣膜原生瓣叶的处理装置及处理方法 |
| CN116616960B (zh) * | 2023-06-01 | 2025-05-23 | 佰仁医疗(江苏)有限公司 | 心脏瓣膜输送器 |
| CN117100459B (zh) * | 2023-10-20 | 2024-08-20 | 北京新尖科技有限公司 | 瓣膜支架及瓣膜假体 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK124690D0 (da) * | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | Klapprotes til implantering i kroppen for erstatning af naturlig klap samt kateter til brug ved implantering af en saadan klapprotese |
| JP4842144B2 (ja) * | 2003-12-23 | 2011-12-21 | サドラ・メディカル・インコーポレーテッド | 再配備可能な心臓弁 |
| US7445631B2 (en) * | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US8323335B2 (en) * | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
| EP4321134A3 (en) * | 2008-11-21 | 2024-05-01 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis and method |
| US8308798B2 (en) * | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
| EP2416739B1 (en) * | 2009-04-10 | 2016-06-08 | Lon Sutherland Annest | An implantable scaffolding containing an orifice for use with a prosthetic or bio-prosthetic valve |
| US8795354B2 (en) * | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
| US9132009B2 (en) * | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
| RU2601799C2 (ru) * | 2011-04-04 | 2016-11-10 | Зэ Медикал Рисерч, Инфрастракче, Энд Хэлс Сервисез Фанд Оф Зэ Тель Авив Медикал Сентер | Устройство и способ для восстановления сердечного клапана |
| US9039757B2 (en) * | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
-
2015
- 2015-10-22 CA CA3214673A patent/CA3214673A1/en active Pending
- 2015-10-22 CN CN201580068145.8A patent/CN107920862B/zh not_active Expired - Fee Related
- 2015-10-22 JP JP2017540974A patent/JP6727218B2/ja not_active Expired - Fee Related
- 2015-10-22 AU AU2015335808A patent/AU2015335808B2/en active Active
- 2015-10-22 CA CA2964935A patent/CA2964935C/en active Active
- 2015-10-22 BR BR112017008423-6A patent/BR112017008423B1/pt active IP Right Grant
-
2017
- 2017-04-23 IL IL251852A patent/IL251852B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4255348A4 (en) * | 2020-12-04 | 2024-08-28 | Hangzhou Sequoia Medical Device Co., Ltd | PROSTHETIC HEART VALVE DEVICE, SYSTEM AND METHODS |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107920862A (zh) | 2018-04-17 |
| JP6727218B2 (ja) | 2020-07-22 |
| BR112017008423B1 (pt) | 2022-07-12 |
| AU2015335808A1 (en) | 2017-04-27 |
| CA2964935C (en) | 2023-10-24 |
| IL251852A0 (en) | 2017-06-29 |
| IL251852B (en) | 2021-07-29 |
| JP2017531547A (ja) | 2017-10-26 |
| CN107920862B (zh) | 2023-03-14 |
| BR112017008423A2 (pt) | 2017-12-26 |
| CA2964935A1 (en) | 2016-04-28 |
| AU2015335808B2 (en) | 2020-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11439506B2 (en) | Systems and methods for heart valve therapy | |
| US20230088407A1 (en) | Systems and methods for heart valve therapy | |
| EP3017792B1 (en) | Systems for heart valve therapy | |
| US10939998B2 (en) | Systems and methods for heart valve therapy | |
| CA2964935C (en) | Systems and methods for heart valve therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230927 |
|
| EEER | Examination request |
Effective date: 20230927 |
|
| EEER | Examination request |
Effective date: 20230927 |